Logistics & Transportation

Articles

Expansion expected to increase global capacity by 75%. 



Joint venture revolves around around the use of raw materials for the development—and ultimately commercialization—of therapies. 



New 25,000 square-foot facility will help grow customers’ gene therapy programs.




Facility addition expected to increase production capacity of TNAs. 






cGMP line will fill vials, syringes, and cartridges, while supporting small-scale commercial production.




South Korea facility expected to provide fill-finish capabilities.




New California plant expected to streamline medicine production.




Investment expected to establish additional cGMPs, expand CDMO services. 




Joint venture expected to address pharma’s injectable drug-filling sector.





Collaboration to support biotech company’s clinical and commercial production efforts.


